Triple

T4949170
Position Surface form Disambiguated ID Type / Status
Subject Fosun International E111125 entity
Predicate owns P347 FINISHED
Object Fosun Pharma
Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
 E483513 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Fosun Pharma | Statement: [Fosun International, owns, Fosun Pharma]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: Fosun Pharma
Context triple: [Fosun International, owns, Fosun Pharma]
  • A. Fosun International
    Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
  • B. Chugai Pharmaceutical
    Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
  • C. Sinopharm
    Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
  • D. Takeda Pharmaceutical Company
    Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
  • E. Eisai
    Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Fosun Pharma
Triple: [Fosun International, owns, Fosun Pharma]
Generated description
Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: Fosun Pharma
Target entity description: Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
  • A. Fosun International
    Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
  • B. Chugai Pharmaceutical
    Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
  • C. Sinopharm
    Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
  • D. Takeda Pharmaceutical Company
    Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
  • E. Eisai
    Eisai is a Japanese pharmaceutical company known for developing treatments in neurology and oncology, including Alzheimer’s disease therapies.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd441721cc819085c7e33fe0876818 completed March 20, 2026, 12:56 p.m.
NER Named-entity recognition batch_69bd7166bb6c8190a40775ac8bb723a8 completed March 20, 2026, 4:10 p.m.
NED1 Entity disambiguation (via context triple) batch_69be81d03b088190aa6601298ee4d8fd completed March 21, 2026, 11:32 a.m.
NEDg Description generation batch_69be8625c100819086b9621b43268164 completed March 21, 2026, 11:51 a.m.
NED2 Entity disambiguation (via description) batch_69be8675c7e08190b01880a679554412 completed March 21, 2026, 11:52 a.m.
Created at: March 20, 2026, 1:31 p.m.